Page 38 - Bioscience Inc News Today

Yield10 Bioscience, Inc. (NASDAQ:NASDAQ:YTEN) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Lynne Brum – Vice President of Planning and Corporate...

-Grower contracts in place for winter 2022/2023 -Development of herbicide tolerance traits in Camelina on track-Collaboration with Rothamsted Research for...

Forward-Looking Statements This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended ,... | November 14, 2022

/PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced...

-Advancing development of herbicide tolerant Camelina- -Building commercial seed inventory available to growers in 2023 and beyond- WOBURN, Mass.,...

/PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its...

/PRNewswire/ -- The "Global Antimicrobial Coatings Market by Type (Silver, Copper, Titanium dioxide), Application (Medical & Healthcare, Foods & Beverages,...

/PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its...

SCOTTSDALE, AZ / ACCESSWIRE / November 9, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company has developed a product

SAN DIEGO, Nov. 08, 2022 -- Daré Bioscience, Inc. , a leader in women’s health innovation, today announced that Sabrina Martucci Johnson, the company’s President and CEO, will... | November 8, 2022